Antiviral Drug Development A Multidisciplinary Approach / edited by Erik De Clercq, Richard T. Walker.

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: De Clercq, Erik (Editor), Walker, Richard T. (Editor)
Format: eBook
Language:English
Published: New York, NY : Springer US : Imprint: Springer, 1988.
Edition:1st ed. 1988.
Series:Nato Science Series A:, Life Sciences ; 143
Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.

MARC

LEADER 00000nam a22000005i 4500
001 b3232651
003 MWH
005 20191026171211.0
007 cr nn 008mamaa
008 121227s1988 xxu| s |||| 0|eng d
020 |a 9781468472752 
024 7 |a 10.1007/978-1-4684-7275-2  |2 doi 
035 |a (DE-He213)978-1-4684-7275-2 
050 4 |a E-Book 
072 7 |a MMG  |2 bicssc 
072 7 |a MED071000  |2 bisacsh 
072 7 |a MKG  |2 thema 
245 1 0 |a Antiviral Drug Development  |h [electronic resource] :  |b A Multidisciplinary Approach /  |c edited by Erik De Clercq, Richard T. Walker. 
250 |a 1st ed. 1988. 
264 1 |a New York, NY :  |b Springer US :  |b Imprint: Springer,  |c 1988. 
300 |a VIII, 314 p. 13 illus.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Nato Science Series A:, Life Sciences ;  |v 143 
490 1 |a Springer eBook Collection 
505 0 |a Antiviral Chemotherapy: An Introduction and Reasons for the Slow Progress, Particularly towards Rational Design -- Design of Nucleoside Analogs as Potential Antiviral Agents -- Design of Anti-Viral Agents other than Nucleoside Analogues -- Antivirals for High Hazards Viruses -- Human Retroviruses and Anti-Viral Therapies -- Epstein-Barr Virus -- Molecular Targets for Selective Antiviral Chemotherapy -- Inhibition of S-Adenosylmethionine-Dependent Transmethylation as an Approach to the Development of Antiviral Agents -- Assay Systems: Testing of Antiviral Drugs in Cell Culture (in vitro) -- Animal Models as Assay Systems for the Development of Antivirals -- Experimental Aspects of Antiviral Pharmacology -- Virus Drug Resistance -- Interferon as an Antiviral Agent -- Risk-Benefit Analysis in Drug Research -- Safety Assessment of Antiviral Drugs -- Antiviral Agents: A New Beginning -- Participants. 
590 |a Loaded electronically. 
590 |a Electronic access restricted to members of the Holy Cross Community. 
650 0 |a Pharmacology. 
650 0 |a Infectious diseases. 
650 0 |a Virology. 
690 |a Electronic resources (E-books) 
700 1 |a De Clercq, Erik.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Walker, Richard T.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
830 0 |a Nato Science Series A:, Life Sciences ;  |v 143 
830 0 |a Springer eBook Collection. 
856 4 0 |u https://holycross.idm.oclc.org/login?auth=cas&url=https://doi.org/10.1007/978-1-4684-7275-2  |3 Click to view e-book 
907 |a .b32326518  |b 04-18-22  |c 02-26-20 
998 |a he  |b 02-26-20  |c m  |d @   |e -  |f eng  |g xxu  |h 0  |i 1 
912 |a ZDB-2-SBL 
912 |a ZDB-2-BAE 
950 |a Biomedical and Life Sciences (Springer-11642) 
902 |a springer purchased ebooks 
903 |a SEB-COLL 
945 |f  - -   |g 1  |h 0  |j  - -   |k  - -   |l he   |o -  |p $0.00  |q -  |r -  |s b   |t 38  |u 0  |v 0  |w 0  |x 0  |y .i21458169  |z 02-26-20 
999 f f |i 6a59535f-210a-5c68-bee6-17405dd6cdb7  |s e46bb0f3-668c-58df-a729-1a4eb0448d32 
952 f f |p Online  |a College of the Holy Cross  |b Main Campus  |c E-Resources  |d Online  |e E-Book  |h Library of Congress classification  |i Elec File  |n 1